Exelixis faces proxy battle with investor Farallon Capital: report by Technical Terrence Team 04/06/2023 0 sanjeri/E+ via Getty Images Update 21:00: Add comment Exelixis. exélixis (NASDAQ:EXEL) will face a proxy battle with hedge fund Farallon ...
Exelixis has mixed ruling in Cabometyx patent trial, wins in 2026, loses in 2030 by Technical Terrence Team 01/20/2023 0 sanjeri/E+ via Getty Images Update 20:15: Add Exelixis's comment. exélixis (NASDAQ:EXEL) had a mixed ruling in its Cabometyx vs. MSN ...